NICE uses wrong comparator to assess cost effectiveness of new drugs, report says
Hawkes, N.
Bmj 348: G2134
2014
ISSN/ISBN: 0959-8138 PMID: 24647344 Document Number: 677563
Document emailed within 1 workday
Related Documents
Splett, P.L. 1991: Phase I: status report of existing data on the effectiveness, cost, and cost effectiveness of nutrition care services Journal of the American Dietetic Association Suppl: S9-14Splett, P.L. 1991: Phase I: status report of existing data on the effectiveness, cost, and cost effectiveness of nutrition care services Journal of the American Dietetic Association Suppl: S9-14
Pollock, K.; Grime, J. 2000: Patients' views on cost effectiveness of drugs are important Bmj 321(7271): 1292
MacDonald, R. 2000: Cost effectiveness of multiple sclerosis drugs remains unknown Bmj 321(7258): 399
Lopert, R.; Lang, D.L.; Hill, S.R.; Henry, D.A. 2002: Differential pricing of drugs: a role for cost-effectiveness analysis? Lancet 359(9323): 2105-2107
Messori, A.; Trippoli, S.; Vaiani, M. 2002: Efficacy, safety, and cost of new anticancer drugs. Price needs to be evaluated against effectiveness Bmj 325(7375): 1302; Author Reply 1302
Hoomans, T.; van der Roer, N.; Severens, J.L.; Delwel, G.O. 2010: Cost-effectiveness of new drugs impacts reimbursement decision making but room for improvement Nederlands Tijdschrift Voor Geneeskunde 154: A958
Boelaert, M.; Le Ray, D.; Van Der Stuyft, P. 2002: How better drugs could change kala-azar control. Lessons from a cost-effectiveness analysis Tropical Medicine and International Health: Tm and Ih 7(11): 955-959
Robertson, K. 2008: The cost of not being nice Practising Midwife 11(7): 5; Author Reply 5
Schulman, K.A.; Kinosian, B.; Jacobson, T.A.; Glick, H.; Willian, M.K.; Koffer, H.; Eisenberg, J.M. 1990: Reducing high blood cholesterol level with drugs. Cost-effectiveness of pharmacologic management JAMA 264(23): 3025-3033
Pope, J.E.; Prashker, M.; Anderson, J. 2004: The efficacy and cost effectiveness of N of 1 studies with diclofenac compared to standard treatment with nonsteroidal antiinflammatory drugs in osteoarthritis Journal of Rheumatology 31(1): 140-149
Goldstein, J.A.; Gurge, R.M. 2008: Treatment of hyperkeratosis with Kerafoam emollient foam (30% urea) to assess effectiveness and safety within a clinical setting: a case study report Journal of Drugs in Dermatology: Jdd 7(2): 159-162
Shade, S.B.; Kevany, S.; Onono, M.; Ochieng, G.; Steinfeld, R.L.; Grossman, D.; Newmann, S.J.; Blat, C.; Bukusi, E.A.; Cohen, C.R. 2013: Cost, cost-efficiency and cost-effectiveness of integrated family planning and HIV services Aids 27(Suppl 1): S87-S92
Ruud Hansen, T.W. 1991: Determination of birth term by early ultrasonic examination--wrong, wrong and wrong again? Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 111(24): 2997-2998
Bratlid, D. 1991: Determination of birth term by early ultrasonic examination--wrong, wrong and wrong again? Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 111(11): 1379-1381
Rooijmans, H.G. 2001: Report of the Dutch Health Council on the cost-effectiveness of long-term psychotherapy Nederlands Tijdschrift Voor Geneeskunde 145(29): 1384-1386
Fletcher, P. 2000: Do NICE and CHI have no interest in safety? Opinion of the book NICE, CHI and the NHS reforms. Enabling excellence or imposing control? Adverse Drug Reactions and Toxicological Reviews 19(3): 167-176
Armstrong, M. 2006: NICE's decision on dementia drugs places nurses in a difficult position Nursing Times 102(43): 12
Mielck, A. 1988: Cost-effectiveness and cost-benefit approaches in programs designed to prevent AIDS Aids and Public Policy Journal 3(3): 19-22
Kahn, J.G.; Jiwani, A.; Gomez, G.B.; Hawkes, S.J.; Chesson, H.W.; Broutet, N.; Kamb, M.L.; Newman, L.M. 2014: The cost and cost-effectiveness of scaling up screening and treatment of syphilis in pregnancy: a model PLOS one 9(1): E87510